Gri Bio Etf Analysis

GRI Etf  USD 0.74  0.05  7.25%   
GRI Bio is undervalued with Real Value of 2.14 and Target Price of 12.0. The main objective of GRI Bio etf analysis is to determine its intrinsic value, which is an estimate of what GRI Bio is worth, separate from its market price. There are two main types of GRI Etf analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic stability of GRI Bio. On the other hand, technical analysis, focuses on the price and volume data of GRI Etf to identify patterns and trends that may indicate its future price movements.
The GRI Bio etf is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and GRI Bio's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GRI Bio. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more detail on how to invest in GRI Etf please use our How to Invest in GRI Bio guide.

GRI Etf Analysis Notes

The fund retains 99.63% of assets under management (AUM) in equities. GRI Bio last dividend was 0.511 per share. The investment seeks investment results that correspond generally to the performance, before the funds fees and expenses, of an index called the Cohen Steers Global Realty Majors Index. Cohen Steers is traded on Archipelago Exchange in USA. To learn more about GRI Bio call the company at 619 400 1170 or check out https://www.gribio.com.

GRI Bio Investment Alerts

GRI Bio is way too risky over 90 days horizon
GRI Bio has some characteristics of a very speculative penny stock
GRI Bio appears to be risky and price may revert if volatility continues
The company reported the last year's revenue of 21.77 M. Reported Net Loss for the year was (13.04 M) with profit before taxes, overhead, and interest of 0.
GRI Bio has about 183.82 M in cash with (9.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.3.
Latest headline from globenewswire.com: GRI Bio Showcases GRI-0621s Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis
The fund retains 99.63% of its assets under management (AUM) in equities

GRI Bio Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to GRI Bio previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
23rd of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

GRI Market Capitalization

The company currently falls under 'Nano-Cap' category with a total capitalization of 6.6 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GRI Bio's market, we take the total number of its shares issued and multiply it by GRI Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

GRI Bio has Return on Asset of (0.8253) % which means that on every $100 spent on assets, it lost $0.8253. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (1.8906) %, meaning that it generated no profit with money invested by stockholders. GRI Bio's management efficiency ratios could be used to measure how well GRI Bio manages its routine affairs as well as how well it operates its assets and liabilities.
The strategic initiatives led by GRI Bio's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Return On Assets
(0.83)
Return On Equity
(1.89)

Top GRI Bio Etf Constituents

Institutional Etf Holders for GRI Bio

Have you ever been surprised when a price of an equity instrument such as GRI Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading GRI Bio backward and forwards among themselves. GRI Bio's institutional investor refers to the entity that pools money to purchase GRI Bio's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Note, although GRI Bio's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Technical Drivers

As of the 26th of November, GRI Bio retains the Market Risk Adjusted Performance of (1.25), risk adjusted performance of 0.0813, and Semi Deviation of 8.26. GRI Bio technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the entity's future prices.

GRI Bio Price Movement Analysis

Execute Study
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. GRI Bio middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for GRI Bio. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

GRI Bio Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific GRI Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on GRI Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases GRI Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

GRI Bio Predictive Daily Indicators

GRI Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of GRI Bio etf daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

GRI Bio Forecast Models

GRI Bio's time-series forecasting models are one of many GRI Bio's etf analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary GRI Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About GRI Etf Analysis

Etf analysis is the technique used by a trader or investor to examine and evaluate how GRI Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling GRI shares will generate the highest return on investment. We also built our etf analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Etf such as GRI Bio. By using and applying GRI Etf analysis, traders can create a robust methodology for identifying GRI entry and exit points for their positions.
The investment seeks investment results that correspond generally to the performance, before the funds fees and expenses, of an index called the Cohen Steers Global Realty Majors Index. Cohen Steers is traded on Archipelago Exchange in USA.

Current GRI Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. GRI analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. GRI analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
12.0Strong Buy1Odds
GRI Bio current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most GRI analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand GRI stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of GRI Bio, talking to its executives and customers, or listening to GRI conference calls.
GRI Analyst Advice Details

GRI Etf Analysis Indicators

GRI Bio etf analysis indicators help investors evaluate how GRI Bio etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading GRI Bio shares will generate the highest return on investment. By understating and applying GRI Bio etf analysis, traders can identify GRI Bio position entry and exit signals to maximize returns.
Begin Period Cash Flow9000.00
Common Stock Shares Outstanding461.6 K
Total Stockholder Equity259 K
Property Plant And Equipment Net22 K
Cash And Short Term Investments1.8 M
Cash1.8 M
Accounts Payable1.4 M
Net Debt-1.8 M
50 Day M A0.6405
Total Current Liabilities2.7 M
Other Operating Expenses11.4 M
Non Current Assets Total22 K
Non Currrent Assets Other-1.00
Stock Based Compensation388 K

Other Information on Investing in GRI Etf

GRI Bio financial ratios help investors to determine whether GRI Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GRI with respect to the benefits of owning GRI Bio security.